NCT06117293 is a NA clinical trial of Mosaic in Skin Texture Disorder, sponsored by CynosureLutronic.

Who is sponsoring NCT06117293?

NCT06117293 is sponsored by CynosureLutronic.

What drugs are being tested in NCT06117293?

Interventions in NCT06117293: Mosaic.

What condition does NCT06117293 study?

NCT06117293 studies Skin Texture Disorder, Photoaging, Wrinkle, Scar, Stretch Mark, Acne Vulgaris, Hair Loss.

Is NCT06117293 still recruiting?

NCT06117293 is currently status unknown. Last updated 7 November 2023.

Last reviewed 2023-11-07 · How we verify

NCT06117293

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Efficacy Evaluation of the Mosaic Ultra Device

Status unknown NA Last updated 7 November 2023

What this trial tests

NA trial testing Mosaic in Skin Texture Disorder in 200 participants. Status unknown.

Timeline

21 February 2023

Primary endpoint
1 September 2024

1 September 2025

Quick facts

Lead sponsor	CynosureLutronic
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	21 February 2023
Primary completion	1 September 2024
Estimated completion	1 September 2025
Sites	3 locations across United States

Drugs / interventions tested

Mosaic

Conditions studied

Skin Texture Disorder — all drugs for Skin Texture Disorder →
Photoaging — all drugs for Photoaging →
Wrinkle — all drugs for Wrinkle →
Scar — all drugs for Scar →

Sponsor

CynosureLutronic — full company profile →

Who can join

Adults 18 to 60, any sex, with Skin Texture Disorder or Photoaging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the Safety and Efficacy of the Mosaic Ultra 1550nm system for the treatment of skin tone and texture, facial rejuvenation, photoaging, wrinkles, scars, stretch marks, acne vulgaris and hair loss.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Skin Texture Disorder

Currently open trials in the same condition.

NCT06868615 — AVAVA MIRIA General Use · NA · recruiting

Other CynosureLutronic trials

Trials by the same sponsor.

NCT06152900 — Safety and Efficacy of Electronic Stimulation for Circumferential Reduction and Muscle Toning · NA · completed
NCT04207047 — Histologic Evaluation of Tissue Following Lutronic System Exposure · NA · unknown
NCT04208100 — Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands · NA · active not recruiting
NCT03534609 — Lutronic Genius System for Neck Treatment · NA · completed
NCT03456674 — LaseMD System for the Treatment of Melasma · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06117293 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CynosureLutronic
Last refreshed: 7 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06117293.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing